DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pramipexole
Pramipexole
Neuroenhancement in Healthy Adults, Part I: Pharmaceutical
Pramipexole V2.1 Last Reviewed: 22/04/2021 Review Date: 22/04/2024
List Item Pramipexole Teva
Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
Sustained Administration of Pramipexole Modifies the Spontaneous Firing of Dopamine, Norepinephrine, and Serotonin Neurons in the Rat Brain
DRUG TREATMENTS for Parkinson's
Pramipexole Dihydrochloride) Tablets, for Oral Use None (4) Initial U.S
Drug Information Quarterly
A Phase 2A Study to Evaluate the Kappa Opioid Receptor As a Target
Acute Management of In-Patient Parkinson's Disease Patients
Dopminergic Treatment of Treatment Refractory Mood Disorders
Behavioral Pharmacology of Dopamine D2 and D3 Receptor Agonists and Antagonists in Rats
Medications for Ataxia Symptoms
Is Pramipexole Safe and Effective in Reducing Depressive Symptoms in Patients with Mild to Moderate Parkinson’S Disease and Depression? Corinne J
FUNCTIONAL SELECTIVITY DOWNSTREAM of Gαi/O-COUPLED RECEPTORS Tarsis Brust Fernandes Purdue University
Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson’S Disease: a Network Meta- Analysis
Psychosis Following the Addition of Pramipexole in an Intellectually Disabled Adult Nancy C
Neupro, INN-Rotigotine
Top View
Anti-Anhedonic Effect of Ketamine and Its Neural Correlates in Treatment-Resistant Bipolar Depression
Pharmacological Approaches to the Management of Resistant Depression
Pnl22 Cost-Effectiveness of Pramipexole Compared With
Neurotransmitters in Health and Disease
Pramipexole Fact Sheet
New Evidence for Reduced Leg Oxygen Levels in Restless Legs Syndrome Erik K
Pramipexole 0.088Mg Tablets
Prefrontal and Limbic Effects of a D3-Preferring Dopamine Agonist
Replication of Ketamine's Antidepressant Efficacy in Bipolar
Clinical Characteristics of Pramipexole-Induced Peripheral Edema
Novel Pharmacological Targets for the Treatment of Parkinson's Disease
Overview of Parkinson's Disease Treatment Options
Efficacy of Ketamine in Bipolar Depression
Therapeutic Class Overview Dopamine Agonists
Association of Dopamine Agonist Use with Impulse Control Disorders in Parkinson Disease
Pharmacologic Therapy for Primary Restless Legs Syndrome a Systematic Review and Meta-Analysis
The Distinct Role of Medium Spiny Neurons and Cholinergic
Update: Treatments for Motor Symptoms of Parkinson's Disease
Mirapex® (Pramipexole Dihydrochloride)
Neuroprotective Effects of Pramipexole in Parkinson's Disease
Specific Aspects of Erectile Dysfunction and Its Treatment for Community Pharmacists
Rotigotine (Neupro) National Drug Monograph March 2013 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
The Efficacy and Safety of Piribedil Relative To
Neuroprotective Agents for Management of Parkinson's Disease
Neupro, INN-Rotigotine
Viekira Pak-RBV and Psychiatric Changes CONFIDENTIAL
Apomorphine (Apokyn®, Kynmobi) EOCCO POLICY
Addiction Research Tools
Review of the Available Evidence on Oral Dopamine Agonists for Parkinson’S Disease
Cardiac Valve Regurgitation with Pergolide Compared with Nonergot Agonists in Parkinson Disease
Treatment of Motor Symptoms of Parkinson's Disease
Drugs Used in Parkinsonism Summary and Questions
Sim Pharmacological-MS CN
Ropinirole 0.25 Mg Shortage
Medicines Fact Sheet
Title 16. Crimes and Offenses Chapter 13. Controlled Substances Article 1
PUBLIC SUMMARY DOCUMENT Product: Pramipexole
New Zealand Data Sheet 1. Name of the Medicinal
Accurate Reference, Accurate Results
5-HT2B Receptor-Mediated Cardiac Valvulopathy
Pharmacology
Pramipexole ESCA: for the Treatment of Parkinson’S Disease
Rhode Island M Edical J Ournal
Harm Reduction for People Who Use Stimulants Harm Reduction for People Who Use Stimulants Use Who People for Reduction Harm
Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease a Survey by the Canadian Movement Disorders Group
Candyflipping and Other Combinations: Identifying Drug–Drug Combinations from an Online Forum
Dopamine Agonists: Pathological Gambling and Increased Libido
Monoamine Oxidase Inhibition by Major Tanshinones from Salvia Miltiorrhiza and Selective Muscarinic Acetylcholine M4 Receptor Antagonism by Tanshinone I
Current and Experimental Therapeutics of Parkinson's
An Experimental Medicine Investigation of the Effects of Subacute Pramipexole Treatment on Emotional Information Processing in Healthy Volunteers